Non-invasive prenatal tests (NIPT) are a more modern and advanced screening method that analyzes small fragments of fetal DNA circulating in the mother's blood. NIPT can be done as early as 10 weeks of pregnancy and is very accurate in detecting certain genetic conditions.

NIPT tests work by analyzing free fetal DNA (cfDNA) present in the mother's blood. These DNA fragments, after being isolated from the mother's blood and properly analyzed, provide genetic information for the fetus. During the test, a sample of blood is taken from the mother and sent to a laboratory, where advanced technologies (NGS) are used to detect chromosomal abnormalities.

1. Early detection: NIPT can be done as early as 10 weeks of pregnancy, allowing for early intervention if needed.
2. High accuracy: NIPT tests have high sensitivity and specificity, significantly reducing the chances of false positive and negative results.
3. Non-invasiveness: Unlike traditional diagnostic tests such as amniocentesis, NIPT involves a simple blood draw, which poses no risk to mother or baby.
4. Comprehensive screening: NIPT can detect a range of chromosomal abnormalities, including Down syndrome (trisomy 21), trisomy 18 and trisomy 13, or over 90 genetic abnormalities.

Preparing for the NIPT test is simple:

1. Consult with your doctor: Discuss the test with your doctor to understand its benefits and limitations.
2. Schedule the test: Schedule the test around the 10th week of pregnancy or later as recommended by your doctor.
3. No special preparation: Unlike some medical tests, NIPT requires no special preparation, but it is always best to consult a genetics laboratory.
4. Discuss the results: Schedule a follow-up appointment to discuss the results and possible next steps.

1. Sensitivity: Sensitivity refers to the ability of a test to accurately identify abnormalities. NIPT has a sensitivity rate of over 99% for detecting Down syndrome.
2. Specificity: Specificity is the ability of a test to accurately identify any abnormalities. NIPT also has a high specificity rate, reducing the likelihood of false positives.
3. Accuracy: Combining high sensitivity and specificity, NIPT offers an overall accuracy of around 99% for common chromosomal abnormalities, making it a reliable screening tool.

Prenatal screening tests can detect a variety of conditions, including:

1. NIFTY® Pro – chromosomal abnormalities: such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13) and other structural and numerical changes (total 94).
2. NIFTY® Mono – Physical abnormalities and mental disorders: Including heart defects and other structural problems.

1. Early detection: Enables early intervention and planning.
2. Non-invasiveness: Most screening tests pose no risk to the mother or the baby.
3. Safe and simple: Ensures safety in terms of baby's health with only 10 ml of mother's blood.
4. Reliability: More than 15 million tests performed worldwide.
5. Fast results